National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

Past Highlights
   
 
Results: 1 -7 of 7         results per page
View Search Criteria | Help With Results
           
Last Modified: 9/1/2002     First Published: 6/1/2000  

1.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Treatment


Completed


18 and over


NCI


OSU-NCI-56
NCI-56, NCT00005864, 56

Last Modified: 7/1/2002     First Published: 1/1/2001  

2.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Treatment


Completed


18 and over


NCI


CHNMC-PHII-26
NCI-57, NCT00008372, 57

Last Modified: 10/1/1993  

3.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Treatment


Completed


18 and over


NCI


MSKCC-93050
NCI-T93-0050D, T93-0050

Last Modified: 11/1/1997  

4.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase I


Treatment


Completed


18 and over


NCI


VCC-9402
NCI-T94-0066D, T94-0066

Last Modified: 12/12/2007  

5.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase I


Treatment


Completed


over 18


NCI


UMCC-8803
NCI-T88-0127C, T88-0127

Last Modified: 7/1/1989  

6.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase I


Treatment


Closed


18 and over


NCI


MSKCC-8860
NCI-T88-0114C, T88-0114

Last Modified: 1/1/1992  

7.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase I


Treatment


Closed


18 and over


NCI


MSKCC-91109
NCI-T91-0183D, T91-0183

   
   

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov